Advocacy Wealth Management, LLC
13F filer · CIK 0001569452Reported Jul 29, 2026
Net buyer this quarter
13F portfolio value$2.75BU.S. long equity reported on 13F
Positions9212 new · 2 closed
Net flow last quarter+$44.7MBuys minus sells
Top 10 positions weight14.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 29, 202692 positions | |||||
| $123M | 4.46% | Not reported | +132.1% | Q4 2023 | |
| PBPMBSPuramed Bioscience Inc. | $53.8M | 1.96% | 0.55% | +2.9% | Q1 2025 |
| $35.1M | 1.27% | 0.54% | +25.1% | Q3 2025 | |
| $32.2M | 1.17% | 9.46% | -38.7% | Q1 2025 | |
| $29M | 1.05% | 0.00% | -0.5% | Q4 2015 | |
| $26.2M | 0.95% | 0.00% | -0.9% | Q2 2013 | |
| $24.1M | 0.88% | 0.00% | +1.7% | Q2 2025 | |
| $23.4M | 0.85% | 0.00% | -0.4% | Q2 2013 | |
| $19.1M | 0.70% | 0.00% | +0.7% | Q2 2013 | |
| $18.7M | 0.68% | 0.01% | -0.9% | Q4 2025 | |
| $18.3M | 0.66% | 0.00% | -0.8% | Q2 2013 | |
| $18M | 0.65% | 0.01% | -1.3% | Q3 2025 | |
| $17.2M | 0.63% | 0.00% | +1.7% | Q2 2013 | |
| $16.8M | 0.61% | 0.01% | +24.5% | Q3 2025 | |
| $15.8M | 0.58% | 0.03% | -1.8% | Q3 2025 | |
| $15.4M | 0.56% | 0.00% | +0.9% | Q2 2013 | |
| $15.3M | 0.56% | 0.01% | +24.4% | Q4 2016 | |
| $14.9M | 0.54% | 0.02% | +6.6% | Q4 2024 | |
| $14.3M | 0.52% | 0.03% | -1.6% | Q3 2025 | |
| $13.9M | 0.51% | 0.01% | -2.1% | Q3 2025 | |
| $13.6M | 0.49% | 0.01% | -3.1% | Q3 2025 | |
| $12.7M | 0.46% | 0.01% | -3.2% | Q3 2025 | |
| $11.5M | 0.42% | 0.00% | -32.7% | Q3 2025 | |
| $11.2M | 0.41% | 0.00% | -1.8% | Q4 2015 | |
| $11.1M | 0.40% | 0.00% | -60.2% | Q3 2025 | |
| $10.5M | 0.38% | 0.01% | -6.5% | Q2 2013 | |
| $10.5M | 0.38% | 0.01% | -14.0% | Q3 2025 | |
| $10.4M | 0.38% | 0.01% | Not reported | Q2 2013 | |
| $9.42M | 0.34% | Not reported | -12.6% | Q3 2025 | |
| $9.29M | 0.34% | 0.01% | -1.9% | Q3 2025 | |
| $8.3M | 0.30% | 0.03% | +98.8% | Q3 2025 | |
| $8.23M | 0.30% | 0.01% | -11.2% | Q3 2025 | |
| $7.42M | 0.27% | 0.01% | -31.4% | Q4 2015 | |
| $5.81M | 0.21% | 0.03% | +2.2% | Q2 2019 | |
| $4.69M | 0.17% | Not reported | New | Q2 2026 | |
| $1.91M | 0.07% | Not reported | +7.8% | Q2 2013 | |
| $1.7M | 0.06% | 0.00% | +0.8% | Q3 2025 | |
| $1.69M | 0.06% | 0.00% | New | Q2 2026 | |
| $1.46M | 0.05% | 0.00% | +5.3% | Q3 2013 | |
| $1.41M | 0.05% | 0.00% | -0.1% | Q3 2025 | |
| $1.38M | 0.05% | Not reported | +1.3% | Q4 2015 | |
| $1.31M | 0.05% | 0.00% | +1.0% | Q3 2025 | |
| $1.26M | 0.05% | 0.00% | +33.7% | Q1 2026 | |
| $1.23M | 0.04% | 0.02% | -0.2% | Q3 2025 | |
| $1.23M | 0.04% | 0.00% | +8.3% | Q2 2013 | |
| $1.19M | 0.04% | 0.00% | -36.3% | Q2 2013 | |
| $1.19M | 0.04% | Not reported | +47.3% | Q3 2025 | |
| $1.16M | 0.04% | 0.00% | +1.0% | Q3 2025 | |
| $1.15M | 0.04% | 0.01% | +0.5% | Q3 2025 | |
| $1.14M | 0.04% | 0.01% | +48.1% | Q4 2025 | |
| Q1 2026Reported May 12, 202682 positions | |||||
| PBPMBSPuramed Bioscience Inc. | $52.5M | 2.32% | 0.53% | -17.2% | Q1 2025 |
| $44.1M | 1.95% | 15.43% | +6.7% | Q1 2025 | |
| $40.6M | 1.80% | Not reported | -8.0% | Q4 2023 | |
| $33.3M | 1.47% | 0.43% | +25.3% | Q3 2025 | |
| $23.4M | 1.04% | 0.00% | -22.8% | Q4 2015 | |
| $20.6M | 0.91% | 0.00% | -1.1% | Q2 2025 | |
| $20.5M | 0.91% | 0.00% | 0.0% | Q2 2013 | |
| $20.3M | 0.90% | 0.00% | -6.6% | Q2 2013 | |
| $18.9M | 0.83% | 0.00% | +11.9% | Q2 2013 | |
| $16.3M | 0.72% | 0.02% | -51.0% | Q4 2024 | |
| $16.2M | 0.72% | 0.00% | -4.1% | Q2 2013 | |
| $15.3M | 0.68% | 0.01% | +43.3% | Q3 2025 | |
| $15.3M | 0.68% | 0.00% | +48.6% | Q4 2015 | |
| $14.9M | 0.66% | 0.01% | +19.5% | Q3 2025 | |
| $14.9M | 0.66% | 0.00% | -0.7% | Q2 2013 | |
| $14.3M | 0.63% | 0.00% | +0.4% | Q2 2013 | |
| $14.3M | 0.63% | 0.01% | +0.3% | Q3 2025 | |
| $14.3M | 0.63% | 0.03% | +33.6% | Q3 2025 | |
| $14.2M | 0.63% | 0.01% | +497.8% | Q4 2025 | |
| $13.5M | 0.60% | 0.01% | +23.7% | Q3 2025 | |
| $13.2M | 0.58% | 0.01% | +7.2% | Q3 2025 | |
| $13.1M | 0.58% | 0.01% | +1.8% | Q3 2025 | |
| $12.8M | 0.57% | 0.01% | +1.3% | Q4 2016 | |
| $12.8M | 0.57% | 0.01% | +60.0% | Q3 2025 | |
| $12.7M | 0.56% | 0.01% | -2.3% | Q2 2013 | |
| $12.1M | 0.54% | 0.01% | -2.0% | Q3 2025 | |
| $11.6M | 0.51% | 0.01% | -0.9% | Q4 2015 | |
| $11.5M | 0.51% | 0.03% | +35.6% | Q3 2025 | |
| $11.4M | 0.50% | 0.00% | -47.8% | Q3 2025 | |
| $9.4M | 0.42% | 0.01% | +48.5% | Q3 2025 | |
| $6.41M | 0.28% | Not reported | +18.6% | Q3 2025 | |
| $5.5M | 0.24% | 0.00% | +0.1% | Q1 2018 | |
| $5.47M | 0.24% | 0.02% | +0.1% | Q2 2019 | |
| $5.23M | 0.23% | 0.01% | -5.3% | Q3 2025 | |
| $4.69M | 0.21% | 0.01% | 0.0% | Q3 2025 | |
| $1.8M | 0.08% | Not reported | +58.2% | Q2 2013 | |
| $1.59M | 0.07% | 0.01% | -86.3% | Q3 2025 | |
| $1.5M | 0.07% | 0.00% | 0.0% | Q3 2025 | |
| $1.48M | 0.07% | 0.00% | +0.4% | Q3 2013 | |
| $1.34M | 0.06% | 0.00% | -0.1% | Q3 2025 | |
| $1.27M | 0.06% | 0.00% | -88.5% | Q3 2025 | |
| $1.19M | 0.05% | 0.00% | 0.0% | Q3 2025 | |
| $1.19M | 0.05% | 0.01% | Not reported | Q3 2025 | |
| $1.15M | 0.05% | 0.00% | +0.2% | Q3 2025 | |
| $1.11M | 0.05% | Not reported | -7.5% | Q4 2015 | |
| $1.06M | 0.05% | 0.00% | -3.0% | Q2 2013 | |
| $1.03M | 0.05% | 0.02% | +24.9% | Q3 2025 | |
| $1.02M | 0.05% | 0.00% | -0.1% | Q1 2016 | |
| $1.02M | 0.04% | 0.00% | -1.7% | Q3 2025 | |
| $997K | 0.04% | 0.00% | -44.4% | Q2 2013 | |
| Q4 2025Reported Feb 11, 202683 positions | |||||
| PBPMBSPuramed Bioscience Inc. | $63.6M | 2.66% | 0.64% | -4.4% | Q1 2025 |
| $44M | 1.84% | 14.46% | +4.8% | Q1 2025 | |
| $40.8M | 1.71% | Not reported | +3.5% | Q4 2023 | |
| $33M | 1.38% | 0.00% | -3.2% | Q4 2015 | |
| $30.7M | 1.29% | 0.05% | -1.5% | Q4 2024 | |
| $25.4M | 1.06% | 0.00% | -3.2% | Q2 2013 | |
| $24.3M | 1.02% | 0.34% | +5.2% | Q3 2025 | |
| $22.7M | 0.95% | 0.00% | -0.7% | Q2 2013 | |
| $22.3M | 0.93% | 0.00% | +7.6% | Q2 2025 | |
| $22M | 0.92% | 0.00% | +10.5% | Q2 2013 | |
| $19.6M | 0.82% | 0.00% | -2.1% | Q2 2013 | |
| $17.6M | 0.74% | 0.00% | -15.2% | Q3 2025 | |
| $16.4M | 0.69% | 0.01% | -1.9% | Q3 2025 | |
| $16.4M | 0.69% | 0.31% | +13.6% | Q3 2025 | |
| $16M | 0.67% | 0.00% | -1.7% | Q2 2013 | |
| $15.9M | 0.67% | 0.01% | -0.7% | Q2 2013 | |
| $15.3M | 0.64% | 0.01% | +17.5% | Q3 2025 | |
| $15.2M | 0.63% | 0.01% | -2.2% | Q3 2025 | |
| $14.8M | 0.62% | 0.01% | -0.5% | Q3 2025 | |
| $13.6M | 0.57% | 0.01% | -6.0% | Q4 2016 | |
| $13.1M | 0.55% | 0.00% | -51.3% | Q2 2013 | |
| $13.1M | 0.55% | 0.01% | +21.0% | Q3 2025 | |
| $12.7M | 0.53% | 0.01% | -2.4% | Q3 2025 | |
| $12.4M | 0.52% | 0.01% | -0.7% | Q3 2025 | |
| $11.9M | 0.50% | 0.01% | -3.8% | Q4 2015 | |
| $11.8M | 0.49% | 0.01% | +16.9% | Q3 2025 | |
| $11.6M | 0.49% | 0.02% | -41.8% | Q3 2025 | |
| $11.4M | 0.48% | 0.02% | -1.6% | Q3 2025 | |
| $11M | 0.46% | 0.02% | -4.2% | Q3 2025 | |
| $10.7M | 0.45% | 0.06% | -6.5% | Q3 2025 | |
| $10.1M | 0.42% | 0.00% | -0.8% | Q4 2015 | |
| $7.95M | 0.33% | 0.01% | -10.2% | Q3 2025 | |
| $7.43M | 0.31% | 0.00% | -5.3% | Q1 2018 | |
| $6.77M | 0.28% | 0.00% | +1611.3% | Q3 2025 | |
| $5.58M | 0.23% | Not reported | -3.5% | Q3 2025 | |
| $5.04M | 0.21% | 0.01% | -17.8% | Q3 2025 | |
| $4.92M | 0.21% | 0.02% | +566.1% | Q2 2019 | |
| $4.91M | 0.21% | 0.01% | +344.8% | Q3 2025 | |
| $3.87M | 0.16% | Not reported | +556.1% | Q2 2013 | |
| $1.53M | 0.06% | 0.00% | New | Q4 2025 | |
| $1.49M | 0.06% | 0.00% | -7.4% | Q3 2025 | |
| $1.31M | 0.05% | Not reported | +1.8% | Q2 2013 | |
| $1.31M | 0.05% | Not reported | +1.1% | Q4 2015 | |
| $1.3M | 0.05% | 0.00% | -19.7% | Q3 2025 | |
| $1.29M | 0.05% | 0.00% | -6.8% | Q3 2025 | |
| $1.27M | 0.05% | 0.00% | +0.5% | Q3 2013 | |
| $1.21M | 0.05% | 0.01% | -7.1% | Q3 2025 | |
| $1.16M | 0.05% | 0.00% | -43.2% | Q2 2013 | |
| $1.14M | 0.05% | 0.00% | -0.2% | Q2 2013 | |
| $1.1M | 0.05% | 0.00% | -7.6% | Q3 2025 | |
| Q3 2025Reported Nov 14, 202583 positions | |||||
| PBPMBSPuramed Bioscience Inc. | $66.5M | 2.88% | 0.67% | +2.3% | Q1 2025 |
| $41.3M | 1.79% | 13.80% | +7.6% | Q1 2025 | |
| $36.7M | 1.59% | Not reported | -1.1% | Q4 2023 | |
| $28M | 1.21% | 0.05% | +8.1% | Q4 2024 | |
| $26.5M | 1.15% | 0.00% | Not reported | Q4 2015 | |
| $25.6M | 1.11% | 0.01% | Not reported | Q2 2013 | |
| $25M | 1.09% | 0.33% | New | Q3 2025 | |
| $21.8M | 0.94% | 0.00% | Not reported | Q2 2013 | |
| $21.4M | 0.93% | 0.00% | +9883.1% | Q2 2013 | |
| $20.5M | 0.89% | 0.00% | +8440.5% | Q2 2025 | |
| $19.5M | 0.85% | 0.00% | Not reported | Q2 2013 | |
| $18.8M | 0.82% | 0.00% | New | Q3 2025 | |
| $18.6M | 0.81% | 0.00% | Not reported | Q2 2013 | |
| $17.5M | 0.76% | 0.03% | New | Q3 2025 | |
| $17.2M | 0.75% | 0.01% | New | Q3 2025 | |
| $17.1M | 0.74% | 0.01% | Not reported | Q2 2013 | |
| $16.7M | 0.73% | 0.01% | New | Q3 2025 | |
| $15.3M | 0.66% | 0.00% | +5970.0% | Q2 2013 | |
| $15.2M | 0.66% | 0.01% | Not reported | Q4 2016 | |
| $14.9M | 0.65% | 0.01% | New | Q3 2025 | |
| $14.8M | 0.64% | 0.01% | New | Q3 2025 | |
| $13.5M | 0.59% | 0.01% | New | Q3 2025 | |
| $13M | 0.56% | 0.00% | Not reported | Q4 2015 | |
| $12.9M | 0.56% | 0.01% | Not reported | Q4 2015 | |
| $12.1M | 0.53% | 0.01% | New | Q3 2025 | |
| $12.1M | 0.52% | 0.01% | New | Q3 2025 | |
| $12M | 0.52% | 0.01% | New | Q3 2025 | |
| $11.6M | 0.50% | 0.02% | New | Q3 2025 | |
| $11.2M | 0.49% | 0.02% | Not reported | Q3 2013 | |
| $10.5M | 0.46% | 0.02% | New | Q3 2025 | |
| $10.5M | 0.46% | 0.02% | New | Q3 2025 | |
| $9.48M | 0.41% | 0.31% | New | Q3 2025 | |
| $8.93M | 0.39% | 0.01% | New | Q3 2025 | |
| $7.89M | 0.34% | 0.06% | New | Q3 2025 | |
| $7.21M | 0.31% | 0.00% | Not reported | Q1 2018 | |
| $6.87M | 0.30% | 0.01% | New | Q3 2025 | |
| $5.67M | 0.25% | Not reported | New | Q3 2025 | |
| $1.91M | 0.08% | 0.00% | Not reported | Q2 2013 | |
| $1.73M | 0.08% | 0.01% | New | Q3 2025 | |
| $1.59M | 0.07% | 0.00% | New | Q3 2025 | |
| $1.56M | 0.07% | 0.00% | New | Q3 2025 | |
| $1.5M | 0.06% | Not reported | New | Q3 2025 | |
| $1.44M | 0.06% | Not reported | Not reported | Q2 2013 | |
| $1.38M | 0.06% | 0.03% | New | Q3 2025 | |
| $1.36M | 0.06% | 0.00% | New | Q3 2025 | |
| $1.36M | 0.06% | 0.00% | Not reported | Q3 2013 | |
| $1.34M | 0.06% | 0.00% | Not reported | Q2 2013 | |
| $1.2M | 0.05% | 0.01% | New | Q3 2025 | |
| $1.16M | 0.05% | 0.01% | New | Q3 2025 | |
| $1.14M | 0.05% | 0.00% | Not reported | Q1 2016 | |
Premium opens every quarter this fund has filed